Answers are grounded in this paper and cite their sources.
This is the peer reviewed version of the following article: Pierce, G.F., Hart, D.P., Kaczmarek, R. and (2019), Safety and efficacy of emicizumab and other novel agents in newborns and infants. Haemophilia, 25: e334-e335. doi:10.1111/hae.13822, which has been published in final form at https://doi.org/10.1111/hae.13822. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions
No takes yet. Share an insight, caveat, or question.
Pierce et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: